The 1993 NIH Revitalization Act sought to encourage more diverse federally funded clinical studies. But, a team of researchers from the University of California, San Francisco and elsewhere reports in PLOS Medicine this week that less than 2 percent of the more than 10,000 National Cancer Institute-funded clinical trials met the goals for the inclusion of minorities.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.